Updates in Hereditary Angioedema Care from the HAEA

Program Overview

This activity will cover HAE genetics and diagnostics with a focus on HAE-nl-C1INH, emerging therapies, and patient-centered care.

Credit Expired

Target Audience

This activity is designed to meet the educational needs of clinicians involved in the diagnosis and management of patients with hereditary angioedema (HAE).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Integrate new developments in hereditary angioedema (HAE) genetic and diagnostic testing
Utilize clinical guidelines to select treatment for prophylaxis and acute attacks in patients with HAE
Provide patient-centered care using individualized management plans and educational resources

Activity Faculty

Anthony J. Castaldo

President/CEO
US HAEA
Fairfax City, VA

Bruce L. Zuraw, MD

Professor, Medicine, UCSD Department of Medicine
Director, US HAE Angioedema Center at UCSD University of California School of Medicine
La Jolla, CA
Research Scientist, Veterans Medical Research Foundation
VA Staff Physician and Chief, Section of Allergy San Diego
Veterans Affairs Medical Center
San Diego, CA

Aleena Banerji, MD

Associate Professor, Medicine
Harvard Medical School
Program and Assistant Clinical Director
Allergy and Immunology Training Program Division of Rheumatology, Allergy and Immunology
Massachusetts General Hospital
Boston, MA

William R. Lumry, MD

Clinical Professor, Internal Medicine
University of Texas Southwestern Medical School
Dallas, TX

Marc A. Riedl, MD, MS

Professor, Medicine
Clinical Director, US HAEA Angioedema Center
Clinical Service Chief, Allergy & Immunology
Division of Rheumatology, Allergy & Immunology
University of California, San Diego
San Diego, CA